DX VX is on Track and Accelerating the Development of Oral Obesity Treatment
- Written by PR Newswire
- Confirmation of effects compared to global late-stage clinical trials
- Accelerating the development of obesity treatment through early licensing out, global joint clinical trials, research funding investment, etc.
SEOUL, South Korea, July 18, 2024 /PRNewswire/ -- DX&VX, which is gaining attention for developing an oral GLP-1 obesity treatment....
Read more: DX VX is on Track and Accelerating the Development of Oral Obesity Treatment














